Globus Medical (GMED) Reports In-Line Q3 EPS
Get the Pulse of the Market with StreetInsider.com's Pulse Picks. Get your Free Trial here.
Globus Medical (NYSE: GMED) reported Q3 EPS of $0.29, in-line with the analyst estimate of $0.29. Revenue for the quarter came in at $135.7 million versus the consensus estimate of $139.25 million.
Globus Medical sees FY2016 EPS of $1.20, versus the consensus of $1.20. Globus Medical sees FY2016 revenue of $560 million, versus the consensus of $574.79 million.
For earnings history and earnings-related data on Globus Medical (GMED) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Vera Bradley (VRA) Tops Q3 EPS by 1c; Offers Light Q4 Outlook; Enters New Licensing Agreements
- Oxford Industries (OXM) Tops Q3 EPS by 2c, Offers Guidance
- SecureWorks Corp. (SCWX) Tops Q3 EPS by 6c; Guides Q4, FY17
Create E-mail Alert Related CategoriesEarnings, Guidance
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!